No Known Direct Interactions
Vascepa (icosapent ethyl), a purified EPA omega-3 fatty acid used to lower triglycerides, has no documented pharmacokinetic or pharmacodynamic interactions with vitamin D supplements or deficiency states. Clinical trials, prescribing information, and drug interaction databases like Drugs.com and Lexicomp report no issues when taken together.[1][2]
Effects on Vitamin D Levels
Some observational studies link omega-3 supplementation, including EPA, to modest increases in serum 25-hydroxyvitamin D levels, possibly due to improved absorption or anti-inflammatory effects on vitamin D metabolism. A 2020 meta-analysis found fish oil raised vitamin D by about 3-5 nmol/L on average, but Vascepa-specific data is limited—its high-purity EPA formulation may produce similar or weaker effects compared to mixed EPA/DHA products.[3][4] No causality is established, and levels stay within normal ranges.
Practical Advice for Patients
- Dosing: Take Vascepa (2g twice daily) with or without vitamin D; no timing adjustments needed.
- Monitoring: Routine vitamin D testing isn't required unless pre-existing deficiency exists. High-dose vitamin D (>4000 IU/day) with Vascepa hasn't shown problems in use.
- Who Might Notice Changes: Patients with low baseline vitamin D or on statins (common Vascepa combo) could see slight benefits from any omega-3 boost to levels.[5]
Related Concerns with Omega-3s
Omega-3s like Vascepa can thin blood mildly, raising bleeding risk with high-dose vitamin E (often paired with D), but vitamin D alone doesn't amplify this. No impact on vitamin D's bone health or immune roles.[2][6]
Sources
[1]: Vascepa Prescribing Information (FDA)
[2]: Drugs.com - Vascepa Interactions
[3]: Nutrients 2020 Meta-Analysis on Omega-3 and Vitamin D
[4]: JAMA Network Open 2018 Study
[5]: American Heart Association Guidelines
[6]: Lexicomp Interaction Checker